CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $736,500 | -9.7% | 25,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $815,500 | -7.3% | 25,000 | 0.0% | 0.01% | -26.3% |
Q1 2023 | $879,750 | -23.2% | 25,000 | 0.0% | 0.02% | -29.6% |
Q4 2022 | $1,145,500 | -5.4% | 25,000 | 0.0% | 0.03% | -3.6% |
Q3 2022 | $1,211,000 | -38.4% | 25,000 | -50.0% | 0.03% | -46.2% |
Q2 2022 | $1,965,000 | -28.8% | 50,000 | -33.3% | 0.05% | -25.7% |
Q1 2022 | $2,761,000 | -39.4% | 75,000 | -25.0% | 0.07% | -22.2% |
Q4 2021 | $4,558,000 | +320.9% | 100,000 | +100.0% | 0.09% | +328.6% |
Q3 2020 | $1,083,000 | +79.0% | 50,000 | 0.0% | 0.02% | +10.5% |
Q2 2017 | $605,000 | – | 50,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |